China has removed import duties on as many as 28 medicines, including all cancer drugs, from May 1, a move which would h...
Refuge Biotechnologies, Inc., a cell therapy company based in California bay area leveraging gene engineering technologi...
Researchers at The Hong Kong University of Science and Technology (HKUST) have identified for the first time the culprit...
Venture capital firm GGV Capital has led a RMB100 million ($15.7 million) series B round in Shanghai-based artificial in...
Australia based Cellmid has recently announced that its wholly owned subsidiary Advangen Limited (“Advangen”...
WuXi Biologics is set to invest $392 million to build a new biologics drug substance manufacturing facility in Ireland. ...
Leading biotech company in China, Innovent Biologics has announced the completion of its $150 million Ser...
Zoetis Inc. recently started the construction of a combined global manufacturing and supply and research and development...
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), has signed an investment agreement with the govern...
Werfen, a global leader in healthcare and life sciences, achieves revenues of 1,337 million euros in 2017, a 1...
Foundation Medicine, Inc. (FM), F. Hoffmann-La Roche Ltd (Roche) and DIAN Diagnostics Group, Co., Ltd. (DIAN), have anno...
Singapore – Shanghai-based Zai Lab Limited inks an exclusive license agreement with privately held Entasis Therape...
MilliporeSigma, a leader in genome editing, has announced that the Chinese Patent Office has issued a notice granting Mi...
Singapore- Tocagen enters into a license agreement with ApolloBio affiliate Beijing Apollo Venus Biomedical Te...
Prenetics, a HongKong-based genetic testing and digital health company, has announced acquisition of DNAFit, a UK-based ...
Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced preliminary results of a phase...
WuXi AppTec is a leading global pharmaceutical and medical device open-access capability and technology platform company...
JHL Biotech recently announced that the China Food and Drug Administration (CFDA) have accepted for review JHL's Clinica...
Royal Philips, a global leader in health technology, and Digital China Health, the largest provider of cloud-based healt...
AK Medical Holdings, a Beijing orthopedic implant maker, has paid $24 million to acquire JRI Orthopedics, UK.&...
CMB International Capital Corporation Ltd, a wholly-owned subsidiary of China Merchants Bank, recently led a $65 million...
Morphotek Inc., a subsidiary of Eisai Inc., has licensed its eribulin-linker payload to Bliss Biopharmaceutical Co., Ltd...
China-based BeiGene, , a commercial-stage biopharmaceutical company focused on developing and commercializing inno...
Ubiquigent Limited has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for t...
CICC Capital Management Company Limited, a wholly-owned subsidiary of China International Capital Corporation Limited (C...
